Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

Volume 327:678-684		September 3, 1992		Number 10

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

K Swedberg, P Held, J Kjekshus, K Rasmussen, L Ryden, and H Wedel

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

Abstract

BACKGROUND. Long-term administration of angiotensin-converting--enzyme (ACE) inhibitors has been shown to improve survival in patients with symptomatic left ventricular failure and to attenuate left ventricular dilatation in patients with myocardial infarction. We studied whether mortality could be reduced during the 6 months after an acute myocardial infarction with use of the ACE inhibitor enalapril. METHODS. At 103 Scandinavian centers patients with acute myocardial infarctions and blood pressure above 100/60 mm Hg were randomly assigned to treatment with either enalapril or placebo, in addition to conventional therapy. Therapy was initiated with an intravenous infusion of enalapril (enalaprilat) within 24 hours after the onset of chest pain, followed by administration of oral enalapril. RESULTS. Of the 6090 patients enrolled, 3046 were assigned to placebo and 3044 to enalapril. The life-table mortality rates in the two groups at one and six months were not significantly different (6.3 and 10.2 percent in the placebo group vs. 7.2 and 11.0 percent in the enalapril group, P = 0.26). The relative risk of death in the enalapril group was 1.10 (95 percent confidence interval, 0.93 to 1.29). Death due to progressive heart failure occurred in 104 patients (3.4 percent) in the placebo group and 132 (4.3 percent) in the enalapril group (P = 0.06). Therapy had to be changed because of worsening heart failure in 30 percent of the placebo group and 27 percent of the enalapril group (P less than 0.006). Early hypotension (systolic pressure less than 90 mm Hg or diastolic pressure less than 50 mm Hg) occurred in 12 percent of the enalapril group and 3 percent of the placebo group (P less than 0.001). CONCLUSIONS. Enalapril therapy started within 24 hours of the onset of acute myocardial infarction does not improve survival during the 180 days after infarction.

Source Information

Department of Medicine, University of Goteborg, Ostra Hospital, Sweden.

This article has been cited by other articles:

Prisant, L. M., Thomas, K. L., Lewis, E. F., Huang, Z., Francis, G. S., Weaver, W. D., Pfeffer, M. A., McMurray, J. J.V., Califf, R. M., Velazquez, E. J. (2008). Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both. J Am Coll Cardiol 51: 1865-1871 [Abstract] [Full Text]
Hernandez, A. F. MD MHS, Harrington, R. A. MD (2008). Comparative effectiveness of angiotensin-converting-enzyme inhibitors: Is an ACE always an ace?. CMAJ 178: 1316-1319 [Full Text]
Yip, G. W (2008). B-type natriuretic peptide: a treatment, not a diagnostic marker. Heart 94: 542-544 [Full Text]
Setoguchi, S., Glynn, R. J., Avorn, J., Mittleman, M. A., Levin, R., Winkelmayer, W. C. (2008). Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-Year Trend Analysis. J Am Coll Cardiol 51: 1247-1254 [Abstract] [Full Text]
Lazar, H. L. (2008). All Coronary Artery Bypass Graft Surgery Patients Will Benefit From Angiotensin-Converting Enzyme Inhibitors. Circulation 117: 6-8 [Full Text]
Borer, J. S. (2007). Angiotensin-converting enzyme inhibition: a landmark advance in treatment for cardiovascular diseases. Eur Heart J Suppl 9: E2-E9 [Abstract] [Full Text]
Pitt, B., Pitt, G. S. (2007). Added Benefit of Mineralocorticoid Receptor Blockade in the Primary Prevention of Sudden Cardiac Death. Circulation 115: 2976-2982 [Full Text]
Egi, M., Bellomo, R., Langenberg, C., Haase, M., Haase, A., Doolan, L., Matalanis, G., Seevenayagam, S., Buxton, B. (2007). Selecting a Vasopressor Drug for Vasoplegic Shock After Adult Cardiac Surgery: A Systematic Literature Review. Ann. Thorac. Surg. 83: 715-723 [Abstract] [Full Text]
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]
Kennedy, L. M.A., Dickstein, K., Anker, S. D., James, M., Cook, T. J., Kristianson, K., Willenheimer, R. (2006). Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease. Eur Heart J 27: 2755-2762 [Abstract] [Full Text]
Pfeffer, M. A., Frohlich, E. D. (2006). Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. Am. J. Physiol. Heart Circ. Physiol. 291: H2021-H2025 [Abstract] [Full Text]
Coca, S. G., Krumholz, H. M., Garg, A. X., Parikh, C. R. (2006). Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.. JAMA 296: 1377-1384 [Abstract] [Full Text]
Tsuyuki, R. T., McDonald, M. A. (2006). Response to Tsuyuki and McDonald. Circulation 114: 855-860 [Full Text]
Massel, D. (2006). Addition of clopidogrel to aspirin, but not early use of metoprolol, improved overall outcome in acute myocardial infarction. Evid. Based Med. 11: 82-83 [Full Text]
Volpe, M., Tocci, G., Pagannone, E. (2006). Fewer Mega-Trials and More Clinically Oriented Studies in Hypertension Research? The Case of Blocking the Renin-Angiotensin-Aldosterone System.. J. Am. Soc. Nephrol. 17: S36-S43 [Abstract] [Full Text]
McMurray, J., Solomon, S., Pieper, K., Reed, S., Rouleau, J., Velazquez, E., White, H., Howlett, J., Swedberg, K., Maggioni, A., Kober, L., Van de Werf, F., Califf, R., Pfeffer, M. (2006). The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction: An Analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol 47: 726-733 [Abstract] [Full Text]
(2005). Part 5: Acute Coronary Syndromes. Circulation 112: III-55-III-72 [Full Text]
McDonald, M. A, Simpson, S. H, Ezekowitz, J. A, Gyenes, G., Tsuyuki, R. T (2005). Angiotensin receptor blockers and risk of myocardial infarction: systematic review. BMJ 331: 873- [Abstract] [Full Text]
Pourdjabbar, A., Parker, T. G., Nguyen, Q. T., Desjardins, J.-F., Lapointe, N., Tsoporis, J. N., Rouleau, J.-L. (2005). Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling. Am. J. Physiol. Heart Circ. Physiol. 288: H1997-H2005 [Abstract] [Full Text]
Anavekar, N. S, Solomon, S. D (2005). Angiotensin II receptor blockade and ventricular remodelling. Journal of Renin-Angiotensin-Aldosterone System 6: 43-48 [Abstract]
Chockalingam, A., Venkatesan, S., Dorairajan, S., Chockalingam, V., Subramaniam, T., Jaganathan, V., Elangovan, S., Alagesan, R., Gnanavelu, G., Arul, A. S. (2005). Safety and Efficacy of Enalapril in Multivalvular Heart Disease with Significant Mitral Stenosis--SCOPE-MS. ANGIOLOGY 56: 151-158 [Abstract]
Lazar, H. L. (2005). Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient. Ann. Thorac. Surg. 79: 1081-1089 [Abstract] [Full Text]
Endorsed by the European Society of Intensive Care, , Authors/Task Force Members, , Nieminen, M. S., Bohm, M., Cowie, M. R., Drexler, H., Filippatos, G. S., Jondeau, G., Hasin, Y., Lopez-Sendon, J., Mebazaa, A., Metra, M., Rhodes, A., Swedberg, K., ESC Committee for Practice Guidelines, , Priori, S. G., Garcia, M. A. A., Blanc, J.-J., Budaj, A., Cowie, M. R, Dean, V., Deckers, J., Burgos, E. F., Lekakis, J., Lindahl, B., Mazzotta, G., Morais, J., Oto, A., Smiseth, O. A., Document Reviewers, , Garcia, M. A. A., Dickstein, K., Albuquerque, A., Conthe, P., Crespo-Leiro, M., Ferrari, R., Follath, F., Gavazzi, A., Janssens, U., Komajda, M., Morais, J., Moreno, R., Singer, M., Singh, S., Tendera, M., Thygesen, K. (2005). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26: 384-416 [Full Text]
de Kam, P. J, Voors, A. A, Fici, F., van Veldhuisen, D. J, van Gilst, W. H (2004). Review: The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era. Journal of Renin-Angiotensin-Aldosterone System 5: 161-168 [Abstract]
Hanania, G, Cambou, J-P, Gueret, P, Vaur, L, Blanchard, D, Lablanche, J-M, Boutalbi, Y, Humbert, R, Clerson, P, Genes, N, Danchin, N, for the USIC 2000 Investigators, (2004). Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 90: 1404-1410 [Abstract] [Full Text]
Ohta, T., Hasebe, N., Tsuji, S., Izawa, K., Jin, Y.-T., Kido, S., Natori, S., Sato, M., Kikuchi, K. (2004). Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol. Am. J. Physiol. Heart Circ. Physiol. 287: H2914-H2921 [Abstract] [Full Text]
Teo, K. K., Mitchell, L. B., Pogue, J., Bosch, J., Dagenais, G., Yusuf, S., on behalf of the HOPE Investigators, (2004). Effect of Ramipril in Reducing Sudden Deaths and Nonfatal Cardiac Arrests in High-Risk Individuals Without Heart Failure or Left Ventricular Dysfunction. Circulation 110: 1413-1417 [Abstract] [Full Text]
Task Force Members, , Lopez-Sendon, J., Swedberg, K., McMurray, J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Pedersen, C. T. (2004). Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 25: 1454-1470 [Full Text]
Pilote, L., Abrahamowicz, M., Rodrigues, E., Eisenberg, M. J., Rahme, E. (2004). Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial Infarction: A Class Effect?. ANN INTERN MED 141: 102-112 [Abstract] [Full Text]
Field, K. M., Pepin, J. L., Mehta, M. D. (2004). Knowing When to Play the Ace: The Use and Under Use of Ace Inhibitors in Primary Practice. Journal of Pharmacy Practice 17: 197-210 [Abstract]
Everly, M. J, Heaton, P. C, Cluxton, R. J Jr (2004). {beta}-Blocker Underuse in Secondary Prevention of Myocardial Infarction. The Annals of Pharmacotherapy 38: 286-293 [Abstract] [Full Text]
Pfeffer, M. A., McMurray, J. J.V., Velazquez, E. J., Rouleau, J.-L., Kober, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., Leimberger, J. D., Henis, M., Edwards, S., Zelenkofske, S., Sellers, M. A., Califf, R. M., the Valsartan in Acute Myocardial Infarction Trial, (2003). Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both. NEJM 349: 1893-1906 [Abstract] [Full Text]
Jin, D., Takai, S., Yamada, M., Sakaguchi, M., Kamoshita, K., Ishida, K., Sukenaga, Y., Miyazaki, M. (2003). Impact of chymase inhibitor on cardiac function and survival after myocardial infarction. Cardiovasc Res 60: 413-420 [Abstract] [Full Text]
van der Elst, M. E, Buurma, H., Bouvy, M. L, de Boer, A. (2003). Drug Therapy for Prevention of Recurrent Myocardial Infarction. The Annals of Pharmacotherapy 37: 1465-1477 [Abstract] [Full Text]
Bertrand, M.E., Bassand, J.-P. (2003). New evidence for angiotensin-converting enzyme inhibition in stroke, cardiac and renal patients: the cardiological approach. Eur Heart J Suppl 5: E1-E3
Ruilope, L. M, Segura, J., Schiffrin, E. L (2003). Review: ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?. Journal of Renin-Angiotensin-Aldosterone System 4: 74-79 [Abstract]
Sugie, T., Kagaya, Y., Takeda, M., Yahagi, H., Takahashi, C., Takahashi, J., Ninomiya, M., Watanabe, J., Ichinohasama, R., Tezuka, F., Shirato, K. (2003). Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?. Cardiovasc Res 58: 611-620 [Abstract] [Full Text]
Zeitz, C. J., Campbell, D. J., Horowitz, J. D. (2003). Myocardial Uptake and Biochemical and Hemodynamic Effects of ACE Inhibitors in Humans. Hypertension 41: 482-487 [Abstract] [Full Text]
Kaluski, E., Kobrin, I., Zimlichman, R., Marmor, A., Krakov, O., Milo, O., Frey, A., Kaplan, S., Krakover, R., Caspi, A., Vered, Z., Cotter, G., RITZ-5 Investigators, (2003). RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study. J Am Coll Cardiol 41: 204-210 [Abstract] [Full Text]
The Task Force on the Management of Acute Myocardi, , Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D. V., Falk, E., Fox, K. A.A., Julian, D., Lengyel, M., Neumann, F.-J., Ruzyllo, W., Thygesen, C., Underwood, S. R., Vahanian, A., Verheugt, F. W.A., Wijns, W. (2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24: 28-66 [Full Text]
Kennedy, H. L., Rosenson, R. S. (2002). Physicians' interpretation of "class effects": A need for thoughtful re-evaluation. J Am Coll Cardiol 40: 19-26 [Abstract] [Full Text]
St. John Sutton, M., Scott, C.H. (2002). A prediction rule for left ventricular dilatation post-MI?. Eur Heart J 23: 509-511 [Full Text]
Allot, E, de Chillou, C, Sadoul, N (2002). Ventricular instability and sudden death in patients with heart failure: lessons from clinical trials. Eur Heart J Suppl 4: D31-D42 [Abstract]
Ruilope, L. M., Schiffrin, E. L. (2001). Blood Pressure Control and Benefits of Antihypertensive Therapy: Does It Make a Difference Which Agents We Use?. Hypertension 38: 537-542 [Abstract] [Full Text]
Cable, D. G. (2001). Invited commentary. Ann. Thorac. Surg. 72: 553-554 [Full Text]
Khalil, M. E., Basher, A. W., Brown, E. J. Jr, Alhaddad, I. A. (2001). A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol 37: 1757-1764 [Abstract] [Full Text]
Furberg, C. D., Pitt, B. (2001). Are all angiotensin-converting enzyme inhibitors interchangeable?. J Am Coll Cardiol 37: 1456-1460 [Abstract] [Full Text]
de Kam, P. J., Voors, A. A., van den Berg, M. P., van Veldhuisen, D. J., Brouwer, J., Crijns, H. J. G. M., Borghi, C., Ambrosioni, E., Hochman, J. S., LeJemtel, T. H., Kingma, J.-H., St. John Sutton, M., van Gilst, W. H., on behalf of the FAMIS CAPTIN and CATS Investigato, (2000). Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: Results of a meta-analysis of 845 patients. J Am Coll Cardiol 36: 2047-2053 [Abstract] [Full Text]
Jansen, R., Niemeyer, M. G., Cleophas, T. J., Zwinderman, A. H. (2000). Factors Influencing Efficacy of Nitrate Therapy for Stable Angina Pectoris: A Multiple Linear Regression Analysis. ANGIOLOGY 51: 1007-1012 [Abstract]
Frances, C. D., Noguchi, H., Massie, B. M., Browner, W. S., McClellan, M. (2000). Are We Inhibited?: Renal Insufficiency Should Not Preclude the Use of ACE Inhibitors for Patients With Myocardial Infarction and Depressed Left Ventricular Function. Arch Intern Med 160: 2645-2650 [Abstract] [Full Text]
Waring, W. S. (2000). Early initiation of ACE inhibitor treatment after acute myocardial infarction - a missed therapeutic opportunity?. Journal of Renin-Angiotensin-Aldosterone System 1: 245-251
Yi Zhun Zhu, , Zhu, Y.-C., Jun Li, , Schafer, H., Schmidt, W., Tai Yao, , Unger, T. (2000). Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction. Journal of Renin-Angiotensin-Aldosterone System 1: 257-262 [Abstract]
Lip, G.Y.H., Lydakis, C., Beevers, D.G. (2000). Management of patients with myocardial infarction and hypertension. Eur Heart J 21: 1125-1134
Kim, S. D., Piano, M. R. (2000). The Natriuretic Peptides: Physiology and Role in Left-Ventricular Dysfunction. Biol Res Nurs 2: 15-29 [Abstract]
Latini, R., Tognoni, G., Maggioni, A. P., Baigent, C., Braunwald, E., Chen, Z.-M., Collins, R., Flather, M., Franzosi, M., Kjekshus, J., Kober, L., Liu, L.-S., Peto, R., Pfeffer, M., Pizzetti, F., Santoro, E., Sleight, P., Swedberg, K., Tavazzi, L., Wang, W., Yusuf, S., on behalf of the Angiotensin-converting Enzyme Inh, (2000). Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: Systematic overview of individual data from 96,712 randomized patients. J Am Coll Cardiol 35: 1801-1807 [Abstract] [Full Text]
Hall, D. (2000). The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not. J Am Coll Cardiol 35: 1808-1812 [Full Text]
Zhu, Y. Z., Lee, H. S., Zhu, Y. Z., Lee, H. S. (2000). Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction. Asian Cardiovasc. Thorac. Ann. 8: 85-90 [Abstract] [Full Text]
Cohn, J. N., Ferrari, R., Sharpe, N., on Behalf of an International Forum on Cardiac Rem, (2000). Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35: 569-582 [Abstract] [Full Text]
Gullestad, L., Aukrust, P.a., Ueland, T., Espevik, T., Yee, G., Vagelos, R., Froland, S. S., Fowler, M. (1999). Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 34: 2061-2067 [Abstract] [Full Text]
Struthers, A D, Anderson, G, MacFadyen, R J, Fraser, C, MacDonald, T M (1999). Non-adherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assays. Heart 82: 584-588 [Abstract] [Full Text]
Faggiotto, A., Paoletti, R. (1999). Statins and Blockers of the Renin-Angiotensin System : Vascular Protection Beyond Their Primary Mode of Action. Hypertension 34: 987-996 [Abstract] [Full Text]
Bastien, N. R., Juneau, A.-V., Ouellette, J., Lambert, C. (1999). Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival. Cardiovasc Res 43: 77-85 [Abstract] [Full Text]
Domanski, M. J., Mitchell, G. F., Norman, J. E., Exner, D. V., Pitt, B., Pfeffer, M. A. (1999). Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33: 951-958 [Abstract] [Full Text]
Domanski, M. J., Exner, D. V., Borkowf, C. B., Geller, N. L., Rosenberg, Y., Pfeffer, M. A. (1999). Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 33: 598-604 [Abstract] [Full Text]
Delong, J. F., Allman, R. M., Sherrill, R. G., Schiesz, N. (1998). A Congestive Heart Failure Project with Measured Improvements in Care. Eval Health Prof 21: 472-486 [Abstract]
Katoh, M., Egashira, K., Usui, M., Ichiki, T., Tomita, H., Shimokawa, H., Rakugi, H., Takeshita, A. (1998). Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats. Circ. Res. 83: 743-751 [Abstract] [Full Text]
McAlister, F. A (1998). Trial is needed of ACE inhibitors plus beta �blockers in survivors of myocardial infarction. BMJ 317: 751a-751 [Full Text]
Rao, A C R, Collinson, P O, Canepa-Anson, R, Joseph, S P (1998). Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 80: 223-225 [Abstract] [Full Text]
Spaulding, C., Charbonnier, B., Cohen-Solal, A., Juilliere, Y., Kromer, E. P., Benhamda, K., Cador, R., Weber, S. (1998). Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril : Results of a Double-Blind, Randomized Comparative Trial. Circulation 98: 757-765 [Abstract] [Full Text]
Hu, K., Gaudron, P., Anders, H.-J., Weidemann, F., Turschner, O., Nahrendorf, M., Ertl, G. (1998). Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Cardiovasc Res 39: 401-412 [Abstract] [Full Text]
(1998). Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction : Systematic Overview of Individual Data From 100 000 Patients in Randomized Trials. Circulation 97: 2202-2212 [Abstract] [Full Text]
Kyriakidis, M., Triposkiadis, F., Dernellis, J., Androulakis, A. E., Mellas, P., Kelepeshis, G. A., Gialafos, J. E. (1998). Effects of Cardiac Versus Circulatory Angiotensin-Converting Enzyme Inhibition on Left Ventricular Diastolic Function and Coronary Blood Flow in Hypertrophic Obstructive Cardiomyopathy. Circulation 97: 1342-1347 [Abstract] [Full Text]
Brown, N. J., Vaughan, D. E. (1998). Angiotensin-Converting Enzyme Inhibitors. Circulation 97: 1411-1420 [Abstract] [Full Text]
Mehta, R. H, Eagle, K. A (1998). Fortnightly review: Secondary prevention in acute myocardial infarction. BMJ 316: 838-842 [Full Text]
Costerousse, O., Allegrini, J., Clozel, J.-P., Ménard, J., Alhenc-Gelas, F. (1998). Angiotensin I-Converting Enzyme Inhibition but Not Angiotensin II Suppression Alters Angiotensin I-Converting Enzyme Gene Expression in Vessels and Epithelia. J. Pharmacol. Exp. Ther. 284: 1180-1187 [Abstract] [Full Text]
Nesto, R. W., Zarich, S. (1998). Acute Myocardial Infarction in Diabetes Mellitus : Lessons Learned From ACE Inhibition. Circulation 97: 12-15 [Full Text]
Webb, C. M., Underwood, R., Anagnostopoulos, C., Bennett, J. G., Pepper, J., Lincoln, C., Collins, P. (1998). The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study. Eur. J. Cardiothorac. Surg. 13: 42-48 [Abstract] [Full Text]
Zuanetti, G., Latini, R., Maggioni, A. P., Franzosi, M., Santoro, L., Tognoni, G., 3 Investigators, G. (1997). Effect of the ACE Inhibitor Lisinopril on Mortality in Diabetic Patients With Acute Myocardial Infarction : Data From the GISSI-3 Study. Circulation 96: 4239-4245 [Abstract] [Full Text]
Brooks, W. W., Bing, O. H. L., Conrad, C. H., O'Neill, L., Crow, M. T., Lakatta, E. G., Dostal, D. E., Baker, K. M., Boluyt, M. O. (1997). Captopril Modifies Gene Expression in Hypertrophied and Failing Hearts of Aged Spontaneously Hypertensive Rats. Hypertension 30: 1362-1368 [Abstract] [Full Text]
Minshall, R. D., Tan, F., Nakamura, F., Rabito, S. F., Becker, R. P., Marcic, B., Erdos, E. G. (1997). Potentiation of the Actions of Bradykinin by Angiotensin I�Converting Enzyme Inhibitors : The Role of Expressed Human Bradykinin B2 Receptors and Angiotensin I�Converting Enzyme in CHO Cells. Circ. Res. 81: 848-856 [Abstract] [Full Text]
Uusimaa, P., Risteli, J., Niemela, M., Lumme, J., Ikaheimo, M., Jounela, A., Peuhkurinen, K. (1997). Collagen Scar Formation After Acute Myocardial Infarction : Relationships to Infarct Size, Left Ventricular Function, and Coronary Artery Patency. Circulation 96: 2565-2572 [Abstract] [Full Text]
Rogers, S. J., Charles, C. J., Sands, J., Richards, A. M., Bridgman, P. G., Gooneratne, R., Ikram, H. (1997). An Ovine Model of Acute Myocardial Infarction and Chronic Left Ventricular Dysfunction. ANGIOLOGY 48: 679-688 [Abstract]
De Marco, T., Goldman, L. (1997). Predicting Outcomes in Severe Heart Failure. Circulation 95: 2597-2599 [Full Text]
Pfeffer, M. A., Greaves, S. C., Arnold, J. M. O., Glynn, R. J., LaMotte, F. S., Lee, R. T., Menapace, F. J. Jr, Rapaport, E., Ridker, P. M., Rouleau, J.-L., Solomon, S. D., Hennekens, C. H. (1997). Early Versus Delayed Angiotensin-Converting Enzyme Inhibition Therapy in Acute Myocardial Infarction : The Healing and Early Afterload Reducing Therapy Trial. Circulation 95: 2643-2651 [Abstract] [Full Text]
Kagaya, Y., Hajjar, R. J., Gwathmey, J. K., Barry, W. H., Lorell, B. H. (1996). Long-term Angiotensin-Converting Enzyme Inhibition With Fosinopril Improves Depressed Responsiveness to Ca2+ in Myocytes From Aortic-Banded Rats. Circulation 94: 2915-2922 [Abstract] [Full Text]
Hennekens, C. H., Albert, C. M., Godfried, S. L., Gaziano, J. M., Buring, J. E. (1996). Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials. NEJM 335: 1660-1668 [Full Text]
Annane, D., Bellissant, E., Pussard, E., Asmar, R., Lacombe, F., Lanata, E., Madonna, O., Safar, M., Giudicelli, J.-F., Gajdos, P. (1996). Placebo-Controlled, Randomized, Double-Blind Study of Intravenous Enalaprilat Efficacy and Safety in Acute Cardiogenic Pulmonary Edema. Circulation 94: 1316-1324 [Abstract] [Full Text]
Omland, T., Aakvaag, A., Bonarjee, V. V. S., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J. A., Dickstein, K. (1996). Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction : Comparison With Plasma Atrial Natriuretic Peptide and N-Terminal Proatrial Natriuretic Peptide. Circulation 93: 1963-1969 [Abstract] [Full Text]
Piana, R. N., Wang, S. Y., Friedman, M., Sellke, F. W. (1996). Angiotensin-Converting Enzyme Inhibition Preserves Endothelium-Dependent Coronary Microvascular Responses During Short-term Ischemia-Reperfusion. Circulation 93: 544-551 [Abstract] [Full Text]
Kober, L., Torp-Pedersen, C., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbak, J., Cole, D. S., Auclert, L., Pauly, N. C., Aliot, E., Persson, S., Camm, A. J., The Trandolapril Cardiac Evaluation (TRACE) study, (1995). A Clinical Trial of the Angiotensin-Converting-Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction. NEJM 333: 1670-1676 [Abstract] [Full Text]
Costanzo, M. R., Augustine, S., Bourge, R., Bristow, M., O'Connell, J. B., Driscoll, D., Rose, E. (1995). Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 92: 3593-3612 [Abstract] [Full Text]
Bohm, M., Castellano, M., Agabiti-Rosei, E., Flesch, M., Paul, M., Erdmann, E. (1995). Dose-Dependent Dissociation of ACE-Inhibitor Effects on Blood Pressure, Cardiac Hypertrophy, and �-Adrenergic Signal Transduction. Circulation 92: 3006-3013 [Abstract] [Full Text]
Latini, R., Maggioni, A. P., Flather, M., Sleight, P., Tognoni, G. (1995). ACE Inhibitor Use in Patients With Myocardial Infarction : Summary of Evidence From Clinical Trials. Circulation 92: 3132-3137 [Full Text]
Anning, P. B., Grocott-Mason, R. M., Lewis, M. J., Shah, A. M. (1995). Enhancement of Left Ventricular Relaxation in the Isolated Heart by an Angiotensin-Converting Enzyme Inhibitor. Circulation 92: 2660-2665 [Abstract] [Full Text]
COMMITTEE MEMBERS, , WILLIAMS, J. F. Jr, BRISTOW, M. R., FOWLER, M. B., FRANCIS, G. S., GARSON, A. Jr, GERSH, B. J., HAMMER, D. F., HLATKY, M. A., LEIER, C. V., PACKER, M., PITT, B., ULLYOT, D. J., WEXLER, L. F., WINTERS, W. L. Jr, TASK FORCE MEMBERS, , RITCHIE, J. L., CHEITLIN, M. D., EAGLE, K. A., GARDNER, T. J., GARSON, A. Jr, GIBBONS, R. J., LEWIS, R. P., O'ROURKE, R. A., RYAN, T. J. (1995). Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 92: 2764-2784 [Full Text]
Cohn, J. N. (1995). Structural Basis for Heart Failure : Ventricular Remodeling and Its Pharmacological Inhibition. Circulation 91: 2504-2507 [Full Text]
Breckenridge, A. (1995). Recent Advances: Clinical pharmacology and therapeutics. BMJ 310: 377-380 [Full Text]
Jugdutt, B. I., Khan, M. I., Jugdutt, S. J., Blinston, G. E. (1995). Effect of Enalapril on Ventricular Remodeling and Function During Healing After Anterior Myocardial Infarction in the Dog. Circulation 91: 802-812 [Abstract] [Full Text]
Falkenhahn, M., Franke, F., Bohle, R. M., Zhu, Y.-C., Stauss, H. M., Bachmann, S., Danilov, S., Unger, T. (1995). Cellular Distribution of Angiotensin-Converting Enzyme After Myocardial Infarction. Hypertension 25: 219-226 [Abstract] [Full Text]

Comments and questions? Please contact us.